474 related articles for article (PubMed ID: 17913795)
41. Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties.
Valentová K; Purchartová K; Rydlová L; Roubalová L; Biedermann D; Petrásková L; Křenková A; Pelantová H; Holečková-Moravcová V; Tesařová E; Cvačka J; Vrba J; Ulrichová J; Křen V
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096957
[TBL] [Abstract][Full Text] [Related]
42. Large-scale isolation of flavonolignans from Silybum marianum extract affords new minor constituents and preliminary structure-activity relationships.
Sy-Cordero A; Graf TN; Nakanishi Y; Wani MC; Agarwal R; Kroll DJ; Oberlies NH
Planta Med; 2010 Apr; 76(6):644-7. PubMed ID: 19941262
[TBL] [Abstract][Full Text] [Related]
43. Dose Effect of Milk Thistle (
Dockalova H; Zeman L; Baholet D; Batik A; Skalickova S; Horky P
Animals (Basel); 2021 Jun; 11(6):. PubMed ID: 34198877
[TBL] [Abstract][Full Text] [Related]
44. Single Laboratory Validation of UHPLC-MS/MS Assays for Six Milk Thistle Flavonolignans in Human Serum.
Muchiri RN; van Breemen RB
J AOAC Int; 2021 Mar; 104(1):232-238. PubMed ID: 33251548
[TBL] [Abstract][Full Text] [Related]
45. Flavonolignans inhibit the arachidonic acid pathway in blood platelets.
Bijak M; Saluk-Bijak J
BMC Complement Altern Med; 2017 Aug; 17(1):396. PubMed ID: 28797264
[TBL] [Abstract][Full Text] [Related]
46. Silychristin derivatives conjugated with coniferylalcohols from silymarin and their pancreatic α-amylase inhibitory activity.
Kato E; Kushibiki N; Satoh H; Kawabata J
Nat Prod Res; 2020 Mar; 34(6):759-765. PubMed ID: 30445852
[TBL] [Abstract][Full Text] [Related]
47. Development of a capillary electrophoresis method for the separation of flavonolignans in silymarin complex.
Riasová P; Jenčo J; Moreno-González D; Vander Heyden Y; Mangelings D; Polášek M; Jáč P
Electrophoresis; 2022 May; 43(9-10):930-938. PubMed ID: 34751959
[TBL] [Abstract][Full Text] [Related]
48. Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin.
Vrba J; Papoušková B; Kosina P; Lněničková K; Valentová K; Ulrichová J
Metabolites; 2020 Aug; 10(8):. PubMed ID: 32806559
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment of milk thistle seed to increase the silymarin yield: an alternative to petroleum ether defatting.
Subramaniam S; Vaughn K; Carrier DJ; Clausen EC
Bioresour Technol; 2008 May; 99(7):2501-6. PubMed ID: 17624768
[TBL] [Abstract][Full Text] [Related]
50. Batch solvent extraction of flavanolignans from milk thistle (Silybum marianum L. Gaertner).
Wallace SN; Carrier DJ; Clausen EC
Phytochem Anal; 2005; 16(1):7-16. PubMed ID: 15688950
[TBL] [Abstract][Full Text] [Related]
51. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers.
Gatti G; Perucca E
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):614-7. PubMed ID: 7874377
[TBL] [Abstract][Full Text] [Related]
52. Absolute configuration of isosilybin A by X-ray crystallography of the heavy atom analogue 7-(4-Bromobenzoyl)isosilybin A.
Sy-Cordero AA; Day CS; Oberlies NH
J Nat Prod; 2012 Nov; 75(11):1879-81. PubMed ID: 23116206
[TBL] [Abstract][Full Text] [Related]
53. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin.
Tvrdý V; Pourová J; Jirkovský E; Křen V; Valentová K; Mladěnka P
Med Res Rev; 2021 Jul; 41(4):2195-2246. PubMed ID: 33587317
[TBL] [Abstract][Full Text] [Related]
54. [Flavonolignans - compounds not only for liver treatment].
Bijak M
Pol Merkur Lekarski; 2017 Jan; 42(247):34-37. PubMed ID: 28134230
[TBL] [Abstract][Full Text] [Related]
55. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
Soleimani V; Delghandi PS; Moallem SA; Karimi G
Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
[TBL] [Abstract][Full Text] [Related]
56. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
Chlopcíková S; Psotová J; Miketová P; Simánek V
Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
[TBL] [Abstract][Full Text] [Related]
57. Chemistry of silybin.
Biedermann D; Vavříková E; Cvak L; Křen V
Nat Prod Rep; 2014 Sep; 31(9):1138-57. PubMed ID: 24977260
[TBL] [Abstract][Full Text] [Related]
58. Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry.
Lee JI; Narayan M; Barrett JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):95-103. PubMed ID: 16942922
[TBL] [Abstract][Full Text] [Related]
59. Interaction of isolated silymarin flavonolignans with iron and copper.
Tvrdý V; Catapano MC; Rawlik T; Karlíčková J; Biedermann D; Křen V; Mladěnka P; Valentová K
J Inorg Biochem; 2018 Dec; 189():115-123. PubMed ID: 30245273
[TBL] [Abstract][Full Text] [Related]
60. The silymarin composition… and why does it matter???
Chambers CS; Holečková V; Petrásková L; Biedermann D; Valentová K; Buchta M; Křen V
Food Res Int; 2017 Oct; 100(Pt 3):339-353. PubMed ID: 28964357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
